M Li
Impact in
-
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
-
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 1
- Journals
- Oncogene (2 papers)Medicine (1 paper)Cell Death and Differentiation (1 paper)Cytotechnology (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
M Li
3 papers receiving 323 citations
Peers
Comparison fields: 5 of 37
- Oncology 169
- Molecular Biology 308
- Cancer Research 47
- Cell Biology 31
- Genetics 51
Countries citing papers authored by M Li
This map shows the geographic impact of M Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Li more than expected).
Fields of papers citing papers by M Li
This network shows the impact of papers produced by M Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Li. The network helps show where M Li may publish in the future.
Co-authorship network
The 14 scholars most cited alongside M Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2011 | 62 | |
| 4 | 2009 | 149 | |
| 5 | 2007 | 119 |
About M Li
M Li is a scholar working on Cancer Research, Nephrology, Oncology, Hematology and Molecular Biology, having authored 5 papers that have together received 330 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Erythropoietin and Anemia Treatment (1 paper), Extracellular vesicles in disease (1 paper), Iron Metabolism and Disorders (1 paper), Ferroptosis and cancer prognosis (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Oncology (169 citations), Molecular Biology (308 citations), Cancer Research (47 citations), Cell Biology (31 citations) and Genetics (51 citations). M Li has collaborated with scholars based in United States and China. Frequent co-authors include Christopher Brooks, Wei Gu, Ning Kon, Thomas Ludwig, Y. Kobayashi, Min Hu, Yigong Shi, Wei Gu, Peter Canoll and Jun Zhong. Their work appears in journals such as Oncogene, Medicine, Cell Death and Differentiation and Cytotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.